Aim. To evaluate the long-term effect of rheohemapheresis (RHF) treatment of age-related macular degeneration (AMD) on photoreceptor IS/OS junction status. Methods. In our study, we followed 24 patients with dry AMD and drusenoid retinal pigment epithelium detachment (DPED) for a period of more than 2.5 years. Twelve patients (22 eyes) were treated by RHF and 12 controls (18 eyes) were randomized. The treated group underwent 8 RHF standardized procedures. We evaluated best-corrected visual acuity, IS/OS junction status (SD OCT), and macular function (multifocal electroretinography) at baseline and at 2.5-year follow-up. Results. RHF caused a decrease of whole-blood viscosity/plasma viscosity at about 15/12%. BCVA of treated patients increased insignificantly (P = 0.187) from median 74.0 letters (56.2 to 81.3 letters) to median 79.0 letters (57.3 to 83.4 letters), but it decreased significantly from 74.0 letters (25.2 to 82.6 letters) to 72.5 letters (23.4 to 83.1 letters) in the control group (P = 0.041). The mfERG responses in the region of eccentricity between 1.8° and 7° were significantly higher in treated patients (P = 0.04). Conclusions. RHF contributed to sparing of photoreceptor IS/OS junction integrity in the fovea, which is assumed to be a predictive factor for preservation of visual acuity.

4th Department of Internal Medicine Hematology Lékařská Fakulta Fakultní Nemocnice Sokolská 581 500 09 Hradec Králové Czech Republic

Department of Gerontology and Metabolic Care Lékařská Fakulta Fakultní Nemocnice Sokolská 581 500 09 Hradec Králové Czech Republic

Department of Ophthalmology Lékařská Fakulta Fakultní Nemocnice Sokolská 581 500 09 Hradec Králové Czech Republic

Department of Radiology Lékařská Fakulta Fakultní Nemocnice Sokolská 581 500 09 Hradec Králové Czech Republic

Zobrazit více v PubMed

Friberg T. R., Bilonick R. A., Brennen P. M. Risk factors for conversion to neovascular age-related macular degeneration based on longitudinal morphologic and visual acuity data. Ophthalmology. 2012;119(7):1432–1437. doi: 10.1016/j.ophtha.2012.02.048. PubMed DOI

Chakravarthy U., Adamis A. P., Cunningham E. T., Jr., et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology. 2006;113(9):1508.e1–1508.e25. PubMed

Rencová E., Bláha M., Studnička J., et al. Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form. Acta Ophthalmologica. 2011;89(5):463–471. doi: 10.1111/j.1755-3768.2009.01710.x. PubMed DOI

Borberg H. 26 years of LDL—apheresis: a review of experience. Transfusion and Apheresis Science. 2009;41(1):49–59. doi: 10.1016/j.transci.2009.05.013. PubMed DOI

Klingel R., Fassbender C., Faßbender T., Göhlen B. Clinical studies to implement Rheopheresis for age-related macular degeneration guided by evidence-based-medicine. Transfusion and Apheresis Science. 2003;29(1):71–84. doi: 10.1016/s1473-0502(03)00101-0. PubMed DOI

Schwartz J., Winters J. L., Padmanabhan A., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. Journal of Clinical Apheresis. 2013;28(3):145–284. doi: 10.1002/jca.21276. PubMed DOI

Bláha M., Rencová E., Langrová H. The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis. Clinical Hemorheology and Microcirculation. 2012;50(4):245–255. PubMed

Klingel R., Fassbender C., Heibges A., et al. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Therapeutic Apheresis and Dialysis. 2010;14(3):276–286. doi: 10.1111/j.1744-9987.2010.00807.x. PubMed DOI

Koss M. J., Kurz P., Tsobanelis T., et al. Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART. Graefe's Archive for Clinical and Experimental Ophthalmology. 2009;247(10):1297–1306. doi: 10.1007/s00417-009-1113-7. PubMed DOI

Sikorski B. L., Bukowska D., Kaluzny J. J., Szkulmowski M., Kowalczyk A., Wojtkowski M. Drusen with accompanying fluid underneath the sensory retina. Ophthalmology. 2011;118(1):82–92. doi: 10.1016/j.ophtha.2010.04.017. PubMed DOI

Kousal B., Záhlava J., Vejvalková S., et al. Molecular-genetic cause and clinical feature in two patients with Stargardt disease. Česká a Slovenská Oftalmologie. 2014;70(6):228–233. PubMed

Studnička J., Rencová E., Bláha M., et al. Long-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration. Journal of Ophthalmology. 2013;2013:8. doi: 10.1155/2013/135798.135798 PubMed DOI PMC

Blaha M., Rencova E., Langrova H., et al. Rheohaemapheresis in the treatment of nonvascular age-related macular degeneration. Atherosclerosis Supplements. 2013;14(1):179–184. doi: 10.1016/j.atherosclerosissup.2012.10.023. PubMed DOI

Augood C. A., Vingerling J. R., de Jong P. T., et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE) Archives of Ophthalmology. 2006;124(4):529–535. PubMed

Grunwald J. E., Daniel E., Ying G., et al. Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology. 2012;119(8):1634–1641. doi: 10.1016/j.ophtha.2012.02.013. PubMed DOI PMC

Marmor M. F., Hood D. C., Keating D., et al. Guidelines for basic multifocal electroretinography (mfERG) Documenta Ophthalmologica. 2003;106(2):105–115. PubMed

Hood D. C., Bach M., Brigell M., et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition) Documenta Ophthalmologica. 2008;116(1):1–11. doi: 10.1007/s10633-007-9089-2. PubMed DOI PMC

Rencová E., Studnicka J., Marák J., Dvoráková H., Langrová H. The coincidence of the junction layer of inner and outer photoreceptors segments (IS/OS) defects localization on SD OCT and functional defects in case of Stargardt disease—a case report. Česká a slovenská oftalmologie. 2012;68(2):84–86. PubMed

Baba T., Yamamoto S., Arai M., et al. Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina. 2008;28(3):453–458. doi: 10.1097/iae.0b013e3181571398. PubMed DOI

Schuman J. S., Puliafito C. A., Fujimoto J. G. Optical Coherence Tomography in Ocular Diseases. 2nd. Thorofare, NJ, USA: Slack Inc; 2004.

Mitamura Y., Hirano K., Baba T., Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. British Journal of Ophthalmology. 2009;93(2):171–175. doi: 10.1136/bjo.2008.146381. PubMed DOI

Iannetti L., Spinucci G., Abbouda A., De Geronimo D., Tortorella P., Accorinti M. Spectral-domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors. Ophthalmologica. 2012;228(1):13–18. doi: 10.1159/000337234. PubMed DOI

Aizawa S., Mitamura Y., Hagiwara A., Sugawara T., Yamamoto S. Changes of fundus autofluorescence, photoreceptor inner and outer segment junction line, and visual function in patients with retinitis pigmentosa. Clinical & Experimental Ophthalmology. 2010;38(6):597–604. doi: 10.1111/j.1442-9071.2010.02321.x. PubMed DOI

Roquet W., Roudot-Thoraval F., Coscas G., Soubrane G. Clinical features of drusenoid pigment epithelial detachment in age related macular degeneration. British Journal of Ophthalmology. 2004;88(5):638–642. doi: 10.1136/bjo.2003.017632. PubMed DOI PMC

Alten F., Clemens C. R., Milojcic C., Eter N. Subretinal drusenoid deposits associated with pigment epithelium detachment in age-related macular degeneration. Retina. 2012;32(9):1727–1732. doi: 10.1097/iae.0b013e3182475b03. PubMed DOI

Bláha M., Rencová E., Studnicka J., et al. Cascade filtration in the therapy of the dry form of age-related macular degeneration. Therapeutic Apheresis and Dialysis. 2009;13(5):453–454. PubMed

Pulido J. S., Winters J. L., Boyer D. Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results. Transactions of the American Ophthalmological Society. 2006;104:221–231. PubMed PMC

Pulido J., Sanders D., Winters J. L., Klingel R. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD) Journal of Clinical Apheresis. 2005;20(3):185–194. doi: 10.1002/jca.20047. PubMed DOI

Soluble endoglin as a biomarker of successful rheopheresis treatment in patients with age-related macular degeneration